Pfizer ‘safe and effective in 12 to 15 year olds’ suggest data
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
A new study carried out in the United States has reported that the Pfizer Covid vaccine is “100 percent effective and well-tolerated” in children aged 12 to 15. The results open the way for the pharmaceutical giant’s jab to be used to vaccinate young teenagers and school children as part of the coronavirus vaccine rollout. Channel 4 News spoke to Professor David Salisbury, the Department of Health’s director of immunisation until 2013, about the data from this latest vaccine trial.
Prof Salisbury told presenter Matt Frei: “We do seem to have got data that says that the vaccine is both safe and effective in 12 to 15-year-olds.
“Which I think is a good step forward.
He explained: “What you have to do with a vaccine when you’ve got recommendations for its use in adults is to progressively go down in the ages of children.
“So you do teenagers then you down to below teenagers and you work your way down progressively demonstrating that the vaccine is safe, demonstrating that is is effective until you get to the youngest age group and then you have a recommendation for all ages.”
JUST IN: Macron faces EU revolt as Yellow Vests call for Frexit and end of Euro
Pressed on whether at-risk young children who are currently shielding should take the jab, he said: “I think the answer to that is you need to be very careful about what are the reasons for them shielding.
“But so far we have very very few reasons not to give vaccines for individuals with comorbid conditions.
“So the answer really is take advice, if you are recommended to have the vaccine have it.
Prof Salisbury’s comments came as medical authorities in Germany advice against the use of the AstraZeneca vaccine in people under the age of 60 because of fears about blood clots.
READ MORE: AstraZeneca slander backfires: EU’s OWN regulator finds ‘no risk factors’ for Covid jab
Emmanuel Macron discusses the vaccine rollout in France
The paediatrician said: “I have very great respect for the European regulators and indeed for the UK regulators and I listen very carefully to their conclusions.
“They have both concluded I believe that the vaccine should be continued to be used because the benefit far outweighs any potential identified risk.
It comes as EU leaders showed a willingness to turn to the Russian manufactured Sputnik V vaccine amid continued attacks on the safety record of the AstraZeneca jab.
Prof Salisbury said the decision to adopt the Russian vaccine leaves the EU open to some “very tough question.”
Starmer claims Covid passports would go against ‘British instinct’ [INSIGHT]
EU blasted for ‘administrative burden’ in Covid vaccine row [ANALYSIS]
Brexit vindicated by vaccine farce ‘EU has nowhere to hide!’ [VIDEO]
The latest 24-hour UK Government figures show a further 43 people are reported to have died with Covid, bringing the total of people who died within 28 days of a positive test to 126,713.
There have been another 4,000 new cases reported in the UK.
Meanwhile, another 224,000 people received their first vaccine dose yesterday.
In total, nearly 31 million people have now received their first Covid vaccine jab
Source: Read Full Article